| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 02/08/2010 | 09:20 | Dow Jones News | Philips Buys Health Business In Israel, No Financial Details | NASDAQ:MEDI | Medtechnica Ltd. |
| 18/06/2007 | 23:37 | PR Newswire (US) | MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv | NASDAQ:MEDI | |
| 12/06/2007 | 20:00 | PR Newswire (US) | MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM) | NASDAQ:MEDI | |
| 26/05/2007 | 00:00 | PR Newswire (US) | MedImmune Receives Correspondence From FDA Regarding FluMist(R) | NASDAQ:MEDI | Medimmune (MM) |
| 24/05/2007 | 18:30 | PR Newswire (US) | MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations | NASDAQ:MEDI | Medimmune (MM) |
| 24/05/2007 | 18:30 | PR Newswire (US) | Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting | NASDAQ:MEDI | Medimmune (MM) |
| 16/05/2007 | 22:17 | PR Newswire (US) | FDA Advisory Committee Recommends Expanded Use of FluMist(R) | NASDAQ:MEDI | Medimmune (MM) |
| 08/05/2007 | 21:30 | PR Newswire (US) | Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings | NASDAQ:MEDI | Medimmune (MM) |
| 08/05/2007 | 19:01 | PR Newswire (US) | MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di | NASDAQ:MEDI | Medimmune (MM) |
| 07/05/2007 | 17:25 | PR Newswire (US) | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
| 07/05/2007 | 17:00 | PR Newswire (US) | MedImmune Provides Fellowship Grants to Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
| 07/05/2007 | 16:30 | PR Newswire (US) | MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease Fellowsh | NASDAQ:MEDI | Medimmune (MM) |
| 02/05/2007 | 22:31 | PR Newswire (US) | MedImmune, Inc. Announces Convertibility of 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 201 | NASDAQ:MEDI | Medimmune (MM) |
| 02/05/2007 | 15:15 | PR Newswire (US) | Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, | NASDAQ:MEDI | Medimmune (MM) |
| 01/05/2007 | 00:30 | PR Newswire (US) | MedImmune Reports Financial Results for 2007 First Quarter | NASDAQ:MEDI | Medimmune (MM) |
| 19/04/2007 | 14:30 | PR Newswire (US) | MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE(R) Molecule | NASDAQ:MEDI | Medimmune (MM) |
| 18/04/2007 | 23:00 | PR Newswire (US) | MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases | NASDAQ:MEDI | Medimmune (MM) |
| 18/04/2007 | 19:05 | PR Newswire (US) | Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) Molecule Targeting CEA | NASDAQ:MEDI | Medimmune (MM) |
| 16/04/2007 | 16:45 | PR Newswire (US) | Icahn Comments on MedImmune Sale Process | NASDAQ:MEDI | Medimmune (MM) |
| 12/04/2007 | 15:38 | PR Newswire (US) | MedImmune Explores Strategic Alternatives | NASDAQ:MEDI | Medimmune (MM) |
| 09/04/2007 | 15:00 | PR Newswire (US) | MedImmune Announces Preliminary Results for 2007 First Quarter | NASDAQ:MEDI | Medimmune (MM) |
| 02/04/2007 | 15:30 | PR Newswire (US) | MedImmune Promotes Three Leaders in Key Scientific & Medical Roles | NASDAQ:MEDI | Medimmune (MM) |
| 02/04/2007 | 15:15 | PR Newswire (US) | MedImmune Announces Addition of Robert H. Hotz To Board of Directors | NASDAQ:MEDI | Medimmune (MM) |
| 30/03/2007 | 16:31 | PR Newswire (US) | Seven Summits Research Releases Alerts on MO, HAL, S, MEDI, and ETFC | NASDAQ:MEDI | Medimmune (MM) |
| 29/03/2007 | 17:45 | PR Newswire (US) | MedImmune Licenses Reverse Genetics Technology to sanofi pasteur for Use in Influenza Vaccine Production | NASDAQ:MEDI | Medimmune (MM) |
| 23/03/2007 | 17:01 | PR Newswire (US) | MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis | NASDAQ:MEDI | Medimmune (MM) |
| 16/03/2007 | 15:31 | PR Newswire (US) | Seven Summits Research Releases Alerts on C, CVX, KFT, MEDI, and KBH | NASDAQ:MEDI | Medimmune (MM) |
| 16/03/2007 | 14:00 | PR Newswire (US) | MedImmune Leases Human Genome Sciences Facility to Expand Cell Culture Influenza Vaccine Manufacturing Capabilities | NASDAQ:MEDI | Medimmune (MM) |
| 12/03/2007 | 22:07 | PR Newswire (US) | MedImmune to Present at the Tenth Annual Lehman Brothers Global Healthcare Conference | NASDAQ:MEDI | Medimmune (MM) |
| 06/03/2007 | 17:00 | PR Newswire (US) | MedImmune to Present at the Cowen & Co. 27th Annual Health Care Conference | NASDAQ:MEDI | Medimmune (MM) |